Evidence map›Paper›PMID 38399947›Full record

ArticleViruses2024

Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV).

Gabriel Montenegro de Campos, Eleonora Cella, Simone Kashima, Luiz Carlos Júnior Alcântara, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Marta Giovanetti, Svetoslav Nanev Slavov

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Gabriel Montenegro de CamposBlood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil.ORCID 0000-0001-5181-415X
Eleonora CellaBurnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA.ORCID 0000-0002-7870-9744
Simone KashimaBlood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil.
Luiz Carlos Júnior AlcântaraInstituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-009, Brazil.ORCID 0000-0002-6769-9931
Sandra Coccuzzo SampaioLaboratory of Cell Cycle, Center for Scientific Development (CDC), Butantan Institute, São Paulo 05503-900, Brazil.
Maria Carolina EliasLaboratory of Cell Cycle, Center for Scientific Development (CDC), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-0501-8280
Marta GiovanettiInstituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-009, Brazil.
Svetoslav Nanev SlavovBlood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil.ORCID 0000-0003-0805-6140
Universidade de São Paulo · BRInstituto Butantan · BRFundação Oswaldo Cruz · BRUniversità Campus Bio-Medico · ITUniversity of Central Florida · US

Funding

National Council for Scientific and Technological Development 305111/2022-1, 403075/2023-8São Paulo Research Foundation 2022/00910-6, 2017/23205-8, 2018/15826-5, 2021/11944-6
6 · The paper itself

Abstract

Nipah virus (NiV), a biosafety level 4 agent, was first identified in human clinical cases during an outbreak in 1998 in Malaysia and Singapore. While flying foxes are the primary host and viral vector, the infection is associated with a severe clinical presentation in humans, resulting in a high mortality rate. Therefore, NiV is considered a virus with an elevated epidemic potential which is further underscored by its recent emergence (September 2023) as an outbreak in India. Given the situation, it is paramount to understand the molecular dynamics of the virus to shed more light on its evolution and prevent potential future outbreaks. In this study, we conducted Bayesian phylogenetic analysis on all available NiV complete genomes, including partial N-gene NiV sequences (≥1000 bp) in public databases since the first human case, registered in 1998. We observed the distribution of genomes into three main clades corresponding to the genotypes Malaysia, Bangladesh and India, with the Malaysian clade being the oldest in evolutionary terms. The Bayesian skyline plot showed a recent increase in the viral population size since 2019. Protein analysis showed the presence of specific protein families (Hendra_C) in bats that might keep the infection in an asymptomatic state in bats, which also serve as viral vectors. Our results further indicate a shortage of complete NiV genomes, which would be instrumental in gaining a better understanding of NiV's molecular evolution and preventing future outbreaks. Our investigation also underscores the critical need to strengthen genomic surveillance based on complete NiV genomes that will aid thorough genetic characterization of the circulating NiV strains and the phylogenetic relationships between the henipaviruses. This approach will better prepare us to tackle the challenges posed by the NiV virus and other emerging viruses.

Indexed as

ChiropteraHenipavirus InfectionsNipah VirusAnimalsBayes TheoremGenetic VariationHumansPhylogenyBayesian phylogenygenotypesNipah virusNiVviral protein families

Identifiers

PMID38399947
PMCPMC10892031
OpenAlexW4391173747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.